Galleto, Lalaine .
HRN: 24-83-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2024
CEFUROXIME 1.5GM (VIAL)
03/21/2024
03/22/2024
IV
1.5gm
Q8 3 Doses
Sp Cs
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes